Prestige Consumer Healthcare (PBH) Equity Average (2011 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Equity Average of $1.8 billion in Q4 2025, down 0.71% quarter-over-quarter from $1.8 billion in Q3 2025, and up 3.81% on a YoY basis from $1.8 billion in Q4 2024.
Prestige Consumer Healthcare (PBH) Equity Average (2011 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Equity Average history runs 15 years deep, the most recent figure standing at $1.8 billion for Q4 2025.
- In Q4 2025, Equity Average rose 3.81% year-over-year to $1.8 billion; the TTM figure through Dec 2025 stood at $1.8 billion (up 3.81% YoY), while the FY2025 annual figure was $1.7 billion, up 12.5% from the prior year.
- Equity Average was $1.8 billion for Q4 2025 at Prestige Consumer Healthcare, down from $1.8 billion in the prior quarter.
- In the past five years, Equity Average ranged from a high of $1.8 billion in Q2 2025 to a low of $1.3 billion in Q1 2021.
- Historically, Equity Average has averaged $1.6 billion across 5 years, with a median of $1.6 billion in 2022.
- The sharpest annual moves came in 2021 and 2023: Equity Average gained 15.7% in 2021, then retreated 7.43% in 2023.
- A 5-year view of Equity Average shows it stood at $1.5 billion in 2021, then gained by 10.96% to $1.7 billion in 2022, then declined by 5.15% to $1.6 billion in 2023, then climbed by 12.23% to $1.8 billion in 2024, then climbed by 3.81% to $1.8 billion in 2025.
- The last three Equity Average figures came in at $1.8 billion (Q4 2025), $1.8 billion (Q3 2025), and $1.8 billion (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 493.55 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.15 Bn |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | 1.83 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.83 Bn |
| Sep 30, 2025 | 1.84 Bn |
| Jun 30, 2025 | 1.85 Bn |
| Mar 31, 2025 | 1.81 Bn |
| Dec 31, 2024 | 1.76 Bn |
| Sep 30, 2024 | 1.71 Bn |
| Jun 30, 2024 | 1.67 Bn |
| Mar 31, 2024 | 1.63 Bn |
| Dec 31, 2023 | 1.57 Bn |
| Sep 30, 2023 | 1.51 Bn |
| Jun 30, 2023 | 1.46 Bn |
| Mar 31, 2023 | 1.57 Bn |
| Dec 31, 2022 | 1.65 Bn |
| Sep 30, 2022 | 1.60 Bn |
| Jun 30, 2022 | 1.58 Bn |
| Mar 31, 2022 | 1.55 Bn |
| Dec 31, 2021 | 1.49 Bn |
| Sep 30, 2021 | 1.44 Bn |
| Jun 30, 2021 | 1.39 Bn |
| Mar 31, 2021 | 1.34 Bn |